Oppenheimer & Co Inc’s Thermo Fisher Scientific Inc Position
Does Oppenheimer & Co Inc own Thermo Fisher Scientific Inc (TMO)? Yes — 28.8K shares worth $14M (+0.17% of its 13F portfolio) as of Q1 2026, down from 29.8K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
28.8K
% of Portfolio
+0.17%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 28.8K | $14M | +0.17% |
| Q4 2025 | 29.8K | $17M | +0.25% |
| Q3 2025 | 30.4K | $15M | +0.18% |
| Q2 2025 | 31.5K | $13M | +0.17% |
| Q1 2025 | 30.3K | $15M | +0.23% |
| Q4 2024 | 29.5K | $15M | +0.23% |
| Q3 2024 | 30.3K | $19M | +0.29% |
| Q2 2024 | 31.4K | $17M | +0.28% |
| Q1 2024 | 31.3K | $18M | +0.30% |
| Q4 2023 | 30.6K | $16M | +0.30% |
| Q3 2023 | 31.7K | $16M | +0.33% |
| Q2 2023 | 32.7K | $17M | +0.34% |
| Q1 2023 | 32.8K | $19M | +0.40% |
| Q4 2022 | 36.7K | $20M | +0.46% |
| Q3 2022 | 36.5K | $19M | +0.43% |
| Q2 2022 | 42.9K | $23M | +0.50% |
| Q1 2022 | 38.8K | $23M | +0.41% |
| Q4 2021 | 40.0K | $27M | +0.47% |
| Q3 2021 | 39.5K | $23M | +0.42% |
| Q2 2021 | 44.2K | $22M | +0.40% |
| Q1 2021 | 42.7K | $19M | +0.39% |
| Q4 2020 | 56.2K | $26M | +0.55% |
| Q3 2020 | 62.2K | $27M | +0.69% |
| Q2 2020 | 77.8K | $28M | +0.73% |
| Q1 2020 | 79.7K | $23M | +0.69% |
| Q4 2019 | 82.1K | $27M | +0.66% |
| Q3 2019 | 85.7K | $25M | +0.68% |
| Q2 2019 | 84.5K | $25M | +0.67% |
| Q1 2019 | 86.9K | $24M | +0.64% |
| Q4 2018 | 87.3K | $20M | +0.61% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer & Co Inc’s full portfolio or all institutional holders of TMO.